STAT3 and cancer: Interestingly, recent studies have also reported that leptin signaling may be involved in the promotion of CSC phenotype [23–25] and that inhibition of STAT3 suppresses leptin-induced CSC activity and cancer progression in diet-induced obese rats [26].